Medical Care
Global Influenza Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 23, 25
- ID: 319829
- Pages: 134
- Figures: 144
- Views: 3
In 2024, the global market size of Influenza Diagnostics was estimated to be worth US$ 2637 million and is forecast to reach approximately US$ 4020 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Influenza Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Diagnostics.
The Influenza Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Influenza Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
Segment by Type
RIDT
RT-PCR
Cell Culture
Others
Segment by Application
Hospitals
POCT
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Influenza Diagnostics in global and regional level.
Chapter 3: Detailed analysis of Influenza Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Influenza Diagnostics revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Influenza Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Diagnostics.
The Influenza Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Influenza Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
Segment by Type
RIDT
RT-PCR
Cell Culture
Others
Segment by Application
Hospitals
POCT
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Influenza Diagnostics in global and regional level.
Chapter 3: Detailed analysis of Influenza Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Influenza Diagnostics revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Influenza Diagnostics Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 RIDT
1.2.3 RT-PCR
1.2.4 Cell Culture
1.2.5 Others
1.3 Market by Application
1.3.1 Global Influenza Diagnostics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Influenza Diagnostics Market Size Estimates and Forecasts
2.2 Influenza Diagnostics Market Size by Region: 2024 Versus 2031
2.2.1 Global Influenza Diagnostics Revenue by Region: 2020-2025
2.2.2 Global Influenza Diagnostics Revenue Forecast by Region (2026-2031)
2.2.3 Global Influenza Diagnostics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Influenza Diagnostics Revenue by Type (2020-2031)
3.1.2 Global Influenza Diagnostics Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Influenza Diagnostics Revenue by Application (2020-2031)
3.2.2 Global Influenza Diagnostics Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 RIDT of Influenza Diagnostics Revenue Market Share by Application
3.3.2 RT-PCR of Influenza Diagnostics Revenue Market Share by Application
3.3.3 Cell Culture of Influenza Diagnostics Revenue Market Share by Application
3.3.4 Others of Influenza Diagnostics Revenue Market Share by Application
4 Global Influenza Diagnostics by Company
4.1 Global Influenza Diagnostics Revenue by Company (2020-2025)
4.2 Global Influenza Diagnostics Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Influenza Diagnostics Companies around the World: Ranking by Revenue
4.3.2 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Influenza Diagnostics Companies Headquarters & Product Type
4.4.1 Global Influenza Diagnostics Companies Headquarters
4.4.2 Date of International Companies Enter into Influenza Diagnostics Market
4.4.3 Global Influenza Diagnostics Companies Product & Service
4.4.4 RIDT Revenue Market Share of Influenza Diagnostics by Company
4.4.5 RT-PCR Revenue Market Share of Influenza Diagnostics by Company
4.4.6 Cell Culture Revenue Market Share of Influenza Diagnostics by Company
4.4.7 Others Revenue Market Share of Influenza Diagnostics by Company
4.5 Global Influenza Diagnostics Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 BD
5.1.1 BD Corporation Information
5.1.2 BD Description, Business Overview
5.1.3 BD Influenza Diagnostics Products Offered
5.1.4 BD Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.1.5 BD Influenza Diagnostics Revenue by Product in 2024
5.1.6 BD Influenza Diagnostics Revenue by Application in 2024
5.1.7 BD Influenza Diagnostics Revenue by Geographic Area in 2024
5.1.8 BD Recent Developments
5.2 Abbott (Include Alere)
5.2.1 Abbott (Include Alere) Corporation Information
5.2.2 Abbott (Include Alere) Description, Business Overview
5.2.3 Abbott (Include Alere) Influenza Diagnostics Products Offered
5.2.4 Abbott (Include Alere) Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.2.5 Abbott (Include Alere) Influenza Diagnostics Revenue by Product in 2024
5.2.6 Abbott (Include Alere) Influenza Diagnostics Revenue by Application in 2024
5.2.7 Abbott (Include Alere) Influenza Diagnostics Revenue by Geographic Area in 2024
5.2.8 Abbott (Include Alere) Recent Developments
5.3 Roche
5.3.1 Roche Corporation Information
5.3.2 Roche Description, Business Overview
5.3.3 Roche Influenza Diagnostics Products Offered
5.3.4 Roche Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.3.5 Roche Influenza Diagnostics Revenue by Product in 2024
5.3.6 Roche Influenza Diagnostics Revenue by Application in 2024
5.3.7 Roche Influenza Diagnostics Revenue by Geographic Area in 2024
5.3.8 Roche Recent Developments
5.4 SIEMENS
5.4.1 SIEMENS Corporation Information
5.4.2 SIEMENS Description, Business Overview
5.4.3 SIEMENS Influenza Diagnostics Products Offered
5.4.4 SIEMENS Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.4.5 SIEMENS Influenza Diagnostics Revenue by Product in 2024
5.4.6 SIEMENS Influenza Diagnostics Revenue by Application in 2024
5.4.7 SIEMENS Influenza Diagnostics Revenue by Geographic Area in 2024
5.4.8 SIEMENS Recent Developments
5.5 Analytik Jena
5.5.1 Analytik Jena Corporation Information
5.5.2 Analytik Jena Description, Business Overview
5.5.3 Analytik Jena Influenza Diagnostics Products Offered
5.5.4 Analytik Jena Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.5.5 Analytik Jena Influenza Diagnostics Revenue by Product in 2024
5.5.6 Analytik Jena Influenza Diagnostics Revenue by Application in 2024
5.5.7 Analytik Jena Influenza Diagnostics Revenue by Geographic Area in 2024
5.5.8 Analytik Jena Recent Developments
5.6 Quidel
5.6.1 Quidel Corporation Information
5.6.2 Quidel Description, Business Overview
5.6.3 Quidel Influenza Diagnostics Products Offered
5.6.4 Quidel Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.6.5 Quidel Influenza Diagnostics Revenue by Product in 2024
5.6.6 Quidel Influenza Diagnostics Revenue by Application in 2024
5.6.7 Quidel Influenza Diagnostics Revenue by Geographic Area in 2024
5.6.8 Quidel Recent Developments
5.7 Thermo Fisher
5.7.1 Thermo Fisher Corporation Information
5.7.2 Thermo Fisher Description, Business Overview
5.7.3 Thermo Fisher Influenza Diagnostics Products Offered
5.7.4 Thermo Fisher Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.7.5 Thermo Fisher Influenza Diagnostics Revenue by Product in 2024
5.7.6 Thermo Fisher Influenza Diagnostics Revenue by Application in 2024
5.7.7 Thermo Fisher Influenza Diagnostics Revenue by Geographic Area in 2024
5.7.8 Thermo Fisher Recent Developments
5.8 Meridian Bioscience
5.8.1 Meridian Bioscience Corporation Information
5.8.2 Meridian Bioscience Description, Business Overview
5.8.3 Meridian Bioscience Influenza Diagnostics Products Offered
5.8.4 Meridian Bioscience Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.8.5 Meridian Bioscience Influenza Diagnostics Revenue by Product in 2024
5.8.6 Meridian Bioscience Influenza Diagnostics Revenue by Application in 2024
5.8.7 Meridian Bioscience Influenza Diagnostics Revenue by Geographic Area in 2024
5.8.8 Meridian Bioscience Recent Developments
5.9 BioMerieux
5.9.1 BioMerieux Corporation Information
5.9.2 BioMerieux Description, Business Overview
5.9.3 BioMerieux Influenza Diagnostics Products Offered
5.9.4 BioMerieux Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.9.5 BioMerieux Influenza Diagnostics Revenue by Product in 2024
5.9.6 BioMerieux Influenza Diagnostics Revenue by Application in 2024
5.9.7 BioMerieux Influenza Diagnostics Revenue by Geographic Area in 2024
5.9.8 BioMerieux Recent Developments
5.10 Sekisui Diagnostics
5.10.1 Sekisui Diagnostics Corporation Information
5.10.2 Sekisui Diagnostics Description, Business Overview
5.10.3 Sekisui Diagnostics Influenza Diagnostics Products Offered
5.10.4 Sekisui Diagnostics Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.10.5 Sekisui Diagnostics Influenza Diagnostics Revenue by Product in 2024
5.10.6 Sekisui Diagnostics Influenza Diagnostics Revenue by Application in 2024
5.10.7 Sekisui Diagnostics Influenza Diagnostics Revenue by Geographic Area in 2024
5.10.8 Sekisui Diagnostics Recent Developments
5.11 Response Biomedical
5.11.1 Response Biomedical Corporation Information
5.11.2 Response Biomedical Description, Business Overview
5.11.3 Response Biomedical Influenza Diagnostics Products Offered
5.11.4 Response Biomedical Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.11.5 Response Biomedical Influenza Diagnostics Revenue by Product in 2024
5.11.6 Response Biomedical Influenza Diagnostics Revenue by Application in 2024
5.11.7 Response Biomedical Influenza Diagnostics Revenue by Geographic Area in 2024
5.11.8 Response Biomedical Recent Developments
5.12 SA Scientific
5.12.1 SA Scientific Corporation Information
5.12.2 SA Scientific Description, Business Overview
5.12.3 SA Scientific Influenza Diagnostics Products Offered
5.12.4 SA Scientific Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.12.5 SA Scientific Influenza Diagnostics Revenue by Product in 2024
5.12.6 SA Scientific Influenza Diagnostics Revenue by Application in 2024
5.12.7 SA Scientific Influenza Diagnostics Revenue by Geographic Area in 2024
5.12.8 SA Scientific Recent Developments
6 North America
6.1 North America Influenza Diagnostics Market Size YoY Growth 2020-2031
6.2 North America Influenza Diagnostics Market Facts & Figures by Country (2020-2031)
6.3 North America Influenza Diagnostics Revenue by Type (2020-2025)
6.4 North America Influenza Diagnostics Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Influenza Diagnostics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Influenza Diagnostics Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Influenza Diagnostics Revenue by Type (2020-2025)
7.4 Asia-Pacific Influenza Diagnostics Revenue by Application (2020-2025)
8 Europe
8.1 Europe Influenza Diagnostics Market Size YoY Growth 2020-2031
8.2 Europe Influenza Diagnostics Market Facts & Figures by Country (2020-2031)
8.3 Europe Influenza Diagnostics Revenue by Type (2020-2025)
8.4 Europe Influenza Diagnostics Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Influenza Diagnostics Market Size YoY Growth 2020-2031
9.2 Latin America Influenza Diagnostics Market Facts & Figures by Country (2020-2031)
9.3 Latin America Influenza Diagnostics Revenue by Type (2020-2025)
9.4 Latin America Influenza Diagnostics Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Influenza Diagnostics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Influenza Diagnostics Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Influenza Diagnostics Revenue by Type (2020-2025)
10.4 Middle East and Africa Influenza Diagnostics Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Influenza Diagnostics Supply Chain Analysis
11.2 Influenza Diagnostics Key Raw Materials and Upstream Suppliers
11.3 Influenza Diagnostics Clients Analysis
11.4 Influenza Diagnostics Sales Channel and Sales Model Analysis
11.4.1 Influenza Diagnostics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Influenza Diagnostics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Influenza Diagnostics Distributors
12 Influenza Diagnostics Market Dynamics
12.1 Influenza Diagnostics Industry Trends
12.2 Influenza Diagnostics Market Drivers
12.3 Influenza Diagnostics Market Challenges
12.4 Influenza Diagnostics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Influenza Diagnostics Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 RIDT
1.2.3 RT-PCR
1.2.4 Cell Culture
1.2.5 Others
1.3 Market by Application
1.3.1 Global Influenza Diagnostics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Influenza Diagnostics Market Size Estimates and Forecasts
2.2 Influenza Diagnostics Market Size by Region: 2024 Versus 2031
2.2.1 Global Influenza Diagnostics Revenue by Region: 2020-2025
2.2.2 Global Influenza Diagnostics Revenue Forecast by Region (2026-2031)
2.2.3 Global Influenza Diagnostics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Influenza Diagnostics Revenue by Type (2020-2031)
3.1.2 Global Influenza Diagnostics Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Influenza Diagnostics Revenue by Application (2020-2031)
3.2.2 Global Influenza Diagnostics Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 RIDT of Influenza Diagnostics Revenue Market Share by Application
3.3.2 RT-PCR of Influenza Diagnostics Revenue Market Share by Application
3.3.3 Cell Culture of Influenza Diagnostics Revenue Market Share by Application
3.3.4 Others of Influenza Diagnostics Revenue Market Share by Application
4 Global Influenza Diagnostics by Company
4.1 Global Influenza Diagnostics Revenue by Company (2020-2025)
4.2 Global Influenza Diagnostics Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Influenza Diagnostics Companies around the World: Ranking by Revenue
4.3.2 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Influenza Diagnostics Companies Headquarters & Product Type
4.4.1 Global Influenza Diagnostics Companies Headquarters
4.4.2 Date of International Companies Enter into Influenza Diagnostics Market
4.4.3 Global Influenza Diagnostics Companies Product & Service
4.4.4 RIDT Revenue Market Share of Influenza Diagnostics by Company
4.4.5 RT-PCR Revenue Market Share of Influenza Diagnostics by Company
4.4.6 Cell Culture Revenue Market Share of Influenza Diagnostics by Company
4.4.7 Others Revenue Market Share of Influenza Diagnostics by Company
4.5 Global Influenza Diagnostics Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 BD
5.1.1 BD Corporation Information
5.1.2 BD Description, Business Overview
5.1.3 BD Influenza Diagnostics Products Offered
5.1.4 BD Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.1.5 BD Influenza Diagnostics Revenue by Product in 2024
5.1.6 BD Influenza Diagnostics Revenue by Application in 2024
5.1.7 BD Influenza Diagnostics Revenue by Geographic Area in 2024
5.1.8 BD Recent Developments
5.2 Abbott (Include Alere)
5.2.1 Abbott (Include Alere) Corporation Information
5.2.2 Abbott (Include Alere) Description, Business Overview
5.2.3 Abbott (Include Alere) Influenza Diagnostics Products Offered
5.2.4 Abbott (Include Alere) Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.2.5 Abbott (Include Alere) Influenza Diagnostics Revenue by Product in 2024
5.2.6 Abbott (Include Alere) Influenza Diagnostics Revenue by Application in 2024
5.2.7 Abbott (Include Alere) Influenza Diagnostics Revenue by Geographic Area in 2024
5.2.8 Abbott (Include Alere) Recent Developments
5.3 Roche
5.3.1 Roche Corporation Information
5.3.2 Roche Description, Business Overview
5.3.3 Roche Influenza Diagnostics Products Offered
5.3.4 Roche Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.3.5 Roche Influenza Diagnostics Revenue by Product in 2024
5.3.6 Roche Influenza Diagnostics Revenue by Application in 2024
5.3.7 Roche Influenza Diagnostics Revenue by Geographic Area in 2024
5.3.8 Roche Recent Developments
5.4 SIEMENS
5.4.1 SIEMENS Corporation Information
5.4.2 SIEMENS Description, Business Overview
5.4.3 SIEMENS Influenza Diagnostics Products Offered
5.4.4 SIEMENS Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.4.5 SIEMENS Influenza Diagnostics Revenue by Product in 2024
5.4.6 SIEMENS Influenza Diagnostics Revenue by Application in 2024
5.4.7 SIEMENS Influenza Diagnostics Revenue by Geographic Area in 2024
5.4.8 SIEMENS Recent Developments
5.5 Analytik Jena
5.5.1 Analytik Jena Corporation Information
5.5.2 Analytik Jena Description, Business Overview
5.5.3 Analytik Jena Influenza Diagnostics Products Offered
5.5.4 Analytik Jena Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.5.5 Analytik Jena Influenza Diagnostics Revenue by Product in 2024
5.5.6 Analytik Jena Influenza Diagnostics Revenue by Application in 2024
5.5.7 Analytik Jena Influenza Diagnostics Revenue by Geographic Area in 2024
5.5.8 Analytik Jena Recent Developments
5.6 Quidel
5.6.1 Quidel Corporation Information
5.6.2 Quidel Description, Business Overview
5.6.3 Quidel Influenza Diagnostics Products Offered
5.6.4 Quidel Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.6.5 Quidel Influenza Diagnostics Revenue by Product in 2024
5.6.6 Quidel Influenza Diagnostics Revenue by Application in 2024
5.6.7 Quidel Influenza Diagnostics Revenue by Geographic Area in 2024
5.6.8 Quidel Recent Developments
5.7 Thermo Fisher
5.7.1 Thermo Fisher Corporation Information
5.7.2 Thermo Fisher Description, Business Overview
5.7.3 Thermo Fisher Influenza Diagnostics Products Offered
5.7.4 Thermo Fisher Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.7.5 Thermo Fisher Influenza Diagnostics Revenue by Product in 2024
5.7.6 Thermo Fisher Influenza Diagnostics Revenue by Application in 2024
5.7.7 Thermo Fisher Influenza Diagnostics Revenue by Geographic Area in 2024
5.7.8 Thermo Fisher Recent Developments
5.8 Meridian Bioscience
5.8.1 Meridian Bioscience Corporation Information
5.8.2 Meridian Bioscience Description, Business Overview
5.8.3 Meridian Bioscience Influenza Diagnostics Products Offered
5.8.4 Meridian Bioscience Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.8.5 Meridian Bioscience Influenza Diagnostics Revenue by Product in 2024
5.8.6 Meridian Bioscience Influenza Diagnostics Revenue by Application in 2024
5.8.7 Meridian Bioscience Influenza Diagnostics Revenue by Geographic Area in 2024
5.8.8 Meridian Bioscience Recent Developments
5.9 BioMerieux
5.9.1 BioMerieux Corporation Information
5.9.2 BioMerieux Description, Business Overview
5.9.3 BioMerieux Influenza Diagnostics Products Offered
5.9.4 BioMerieux Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.9.5 BioMerieux Influenza Diagnostics Revenue by Product in 2024
5.9.6 BioMerieux Influenza Diagnostics Revenue by Application in 2024
5.9.7 BioMerieux Influenza Diagnostics Revenue by Geographic Area in 2024
5.9.8 BioMerieux Recent Developments
5.10 Sekisui Diagnostics
5.10.1 Sekisui Diagnostics Corporation Information
5.10.2 Sekisui Diagnostics Description, Business Overview
5.10.3 Sekisui Diagnostics Influenza Diagnostics Products Offered
5.10.4 Sekisui Diagnostics Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.10.5 Sekisui Diagnostics Influenza Diagnostics Revenue by Product in 2024
5.10.6 Sekisui Diagnostics Influenza Diagnostics Revenue by Application in 2024
5.10.7 Sekisui Diagnostics Influenza Diagnostics Revenue by Geographic Area in 2024
5.10.8 Sekisui Diagnostics Recent Developments
5.11 Response Biomedical
5.11.1 Response Biomedical Corporation Information
5.11.2 Response Biomedical Description, Business Overview
5.11.3 Response Biomedical Influenza Diagnostics Products Offered
5.11.4 Response Biomedical Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.11.5 Response Biomedical Influenza Diagnostics Revenue by Product in 2024
5.11.6 Response Biomedical Influenza Diagnostics Revenue by Application in 2024
5.11.7 Response Biomedical Influenza Diagnostics Revenue by Geographic Area in 2024
5.11.8 Response Biomedical Recent Developments
5.12 SA Scientific
5.12.1 SA Scientific Corporation Information
5.12.2 SA Scientific Description, Business Overview
5.12.3 SA Scientific Influenza Diagnostics Products Offered
5.12.4 SA Scientific Influenza Diagnostics Revenue and Gross Margin (2020-2025)
5.12.5 SA Scientific Influenza Diagnostics Revenue by Product in 2024
5.12.6 SA Scientific Influenza Diagnostics Revenue by Application in 2024
5.12.7 SA Scientific Influenza Diagnostics Revenue by Geographic Area in 2024
5.12.8 SA Scientific Recent Developments
6 North America
6.1 North America Influenza Diagnostics Market Size YoY Growth 2020-2031
6.2 North America Influenza Diagnostics Market Facts & Figures by Country (2020-2031)
6.3 North America Influenza Diagnostics Revenue by Type (2020-2025)
6.4 North America Influenza Diagnostics Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Influenza Diagnostics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Influenza Diagnostics Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Influenza Diagnostics Revenue by Type (2020-2025)
7.4 Asia-Pacific Influenza Diagnostics Revenue by Application (2020-2025)
8 Europe
8.1 Europe Influenza Diagnostics Market Size YoY Growth 2020-2031
8.2 Europe Influenza Diagnostics Market Facts & Figures by Country (2020-2031)
8.3 Europe Influenza Diagnostics Revenue by Type (2020-2025)
8.4 Europe Influenza Diagnostics Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Influenza Diagnostics Market Size YoY Growth 2020-2031
9.2 Latin America Influenza Diagnostics Market Facts & Figures by Country (2020-2031)
9.3 Latin America Influenza Diagnostics Revenue by Type (2020-2025)
9.4 Latin America Influenza Diagnostics Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Influenza Diagnostics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Influenza Diagnostics Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Influenza Diagnostics Revenue by Type (2020-2025)
10.4 Middle East and Africa Influenza Diagnostics Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Influenza Diagnostics Supply Chain Analysis
11.2 Influenza Diagnostics Key Raw Materials and Upstream Suppliers
11.3 Influenza Diagnostics Clients Analysis
11.4 Influenza Diagnostics Sales Channel and Sales Model Analysis
11.4.1 Influenza Diagnostics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Influenza Diagnostics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Influenza Diagnostics Distributors
12 Influenza Diagnostics Market Dynamics
12.1 Influenza Diagnostics Industry Trends
12.2 Influenza Diagnostics Market Drivers
12.3 Influenza Diagnostics Market Challenges
12.4 Influenza Diagnostics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Influenza Diagnostics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Influenza Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Influenza Diagnostics Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Influenza Diagnostics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Influenza Diagnostics Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Influenza Diagnostics Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Influenza Diagnostics Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Influenza Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 11. Influenza Diagnostics Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Influenza Diagnostics Players by Revenue (US$ Million) in 2024
Table 13. Global Influenza Diagnostics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Influenza Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2024)
Table 15. Global Influenza Diagnostics Companies Headquarters
Table 16. Date of International Companies Enter into Influenza Diagnostics Market
Table 17. Global Influenza Diagnostics Companies Product & Service
Table 18. Global Influenza Diagnostics Mergers & Acquisitions, Expansion Plans
Table 19. BD Corporation Information
Table 20. BD Description and Business Overview
Table 21. BD Influenza Diagnostics Product
Table 22. BD Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. BD Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 24. BD Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 25. BD Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 26. BD Recent Developments
Table 27. Abbott (Include Alere) Corporation Information
Table 28. Abbott (Include Alere) Description and Business Overview
Table 29. Abbott (Include Alere) Influenza Diagnostics Product
Table 30. Abbott (Include Alere) Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Abbott (Include Alere) Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 32. Abbott (Include Alere) Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 33. Abbott (Include Alere) Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 34. Abbott (Include Alere) Recent Developments
Table 35. Roche Corporation Information
Table 36. Roche Description and Business Overview
Table 37. Roche Influenza Diagnostics Product
Table 38. Roche Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Roche Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 40. Roche Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 41. Roche Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 42. Roche Recent Developments
Table 43. SIEMENS Corporation Information
Table 44. SIEMENS Description and Business Overview
Table 45. SIEMENS Influenza Diagnostics Product
Table 46. SIEMENS Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. SIEMENS Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 48. SIEMENS Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 49. SIEMENS Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 50. SIEMENS Recent Developments
Table 51. Analytik Jena Corporation Information
Table 52. Analytik Jena Description and Business Overview
Table 53. Analytik Jena Influenza Diagnostics Product
Table 54. Analytik Jena Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Analytik Jena Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 56. Analytik Jena Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 57. Analytik Jena Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 58. Analytik Jena Recent Developments
Table 59. Quidel Corporation Information
Table 60. Quidel Description and Business Overview
Table 61. Quidel Influenza Diagnostics Product
Table 62. Quidel Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Quidel Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 64. Quidel Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 65. Quidel Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 66. Quidel Recent Developments
Table 67. Thermo Fisher Corporation Information
Table 68. Thermo Fisher Description and Business Overview
Table 69. Thermo Fisher Influenza Diagnostics Product
Table 70. Thermo Fisher Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 72. Thermo Fisher Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 73. Thermo Fisher Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 74. Thermo Fisher Recent Developments
Table 75. Meridian Bioscience Corporation Information
Table 76. Meridian Bioscience Description and Business Overview
Table 77. Meridian Bioscience Influenza Diagnostics Product
Table 78. Meridian Bioscience Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Meridian Bioscience Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 80. Meridian Bioscience Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 81. Meridian Bioscience Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 82. Meridian Bioscience Recent Developments
Table 83. BioMerieux Corporation Information
Table 84. BioMerieux Description and Business Overview
Table 85. BioMerieux Influenza Diagnostics Product
Table 86. BioMerieux Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. BioMerieux Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 88. BioMerieux Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 89. BioMerieux Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 90. BioMerieux Recent Developments
Table 91. Sekisui Diagnostics Corporation Information
Table 92. Sekisui Diagnostics Description and Business Overview
Table 93. Sekisui Diagnostics Influenza Diagnostics Product
Table 94. Sekisui Diagnostics Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Sekisui Diagnostics Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 96. Sekisui Diagnostics Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 97. Sekisui Diagnostics Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 98. Sekisui Diagnostics Recent Developments
Table 99. Response Biomedical Corporation Information
Table 100. Response Biomedical Description and Business Overview
Table 101. Response Biomedical Influenza Diagnostics Product
Table 102. Response Biomedical Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Response Biomedical Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 104. Response Biomedical Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 105. Response Biomedical Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 106. Response Biomedical Recent Developments
Table 107. SA Scientific Corporation Information
Table 108. SA Scientific Description and Business Overview
Table 109. SA Scientific Influenza Diagnostics Product
Table 110. SA Scientific Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. SA Scientific Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 112. SA Scientific Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 113. SA Scientific Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 114. SA Scientific Recent Developments
Table 115. North America Influenza Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 116. North America Influenza Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 117. North America Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 118. North America Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 119. Asia-Pacific Influenza Diagnostics Revenue by Region (2020-2025) & (US$ Million)
Table 120. Asia-Pacific Influenza Diagnostics Revenue by Region (2026-2031) & (US$ Million)
Table 121. Asia-Pacific Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 122. Asia-Pacific Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 123. Europe Influenza Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 124. Europe Influenza Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 125. Europe Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 126. Europe Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 127. Latin America Influenza Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 128. Latin America Influenza Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 129. Latin America Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 130. Latin America Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 131. Middle East and Africa Influenza Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 132. Middle East and Africa Influenza Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 133. Middle East and Africa Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 134. Middle East and Africa Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 135. Influenza Diagnostics Key Raw Materials, Industry Status and Trend
Table 136. Influenza Diagnostics Key Raw Materials and Upstream Suppliers
Table 137. Influenza Diagnostics Clients Status and Trend
Table 138. Influenza Diagnostics Typical Clients
Table 139. Influenza Diagnostics Distributors
Table 140. Influenza Diagnostics Market Trends
Table 141. Influenza Diagnostics Market Drivers
Table 142. Influenza Diagnostics Market Challenges
Table 143. Influenza Diagnostics Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Diagnostics Product Picture
Figure 2. Global Influenza Diagnostics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Influenza Diagnostics Revenue Market Share by Type in 2024 & 2031
Figure 4. RIDT Product Picture
Figure 5. RT-PCR Product Picture
Figure 6. Cell Culture Product Picture
Figure 7. Others Product Picture
Figure 8. Global Influenza Diagnostics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Influenza Diagnostics Revenue Market Share by Application in 2024 & 2031
Figure 10. Hospitals
Figure 11. POCT
Figure 12. Others
Figure 13. Influenza Diagnostics Report Years Considered
Figure 14. Global Influenza Diagnostics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Influenza Diagnostics Market Size (2020-2031) & (US$ Million)
Figure 16. Global Influenza Diagnostics Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Influenza Diagnostics Revenue Market Share by Region (2020-2031)
Figure 18. Global Influenza Diagnostics Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Influenza Diagnostics Revenue Market Share Forecast by Application (2020-2031)
Figure 20. RIDT of Influenza Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 21. RT-PCR of Influenza Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 22. Cell Culture of Influenza Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 23. Others of Influenza Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 24. Influenza Diagnostics Revenue Share by Company (2024)
Figure 25. Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. RIDT Revenue Proportion by Company in 2024
Figure 27. RT-PCR Revenue Proportion by Company in 2024
Figure 28. Cell Culture Revenue Proportion by Company in 2024
Figure 29. Others Revenue Proportion by Company in 2024
Figure 30. North America Influenza Diagnostics Revenue 2020-2031 (US$ Million)
Figure 31. North America Influenza Diagnostics Revenue Market Share by Type (2020-2025)
Figure 32. North America Influenza Diagnostics Revenue Market Share by Application (2020-2025)
Figure 33. Asia-Pacific Influenza Diagnostics Revenue 2020-2031 (US$ Million)
Figure 34. Asia-Pacific Influenza Diagnostics Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Influenza Diagnostics Revenue Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Influenza Diagnostics Revenue Market Share by Application (2020-2025)
Figure 37. Europe Influenza Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Influenza Diagnostics Revenue Market Share by Country (2020-2031)
Figure 39. Europe Influenza Diagnostics Revenue Market Share by Type (2020-2025)
Figure 40. Europe Influenza Diagnostics Revenue Market Share by Application (2020-2025)
Figure 41. Latin America Influenza Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Influenza Diagnostics Revenue Market Share by Country (2020-2031)
Figure 43. Latin America Influenza Diagnostics Revenue Market Share by Type (2020-2025)
Figure 44. Latin America Influenza Diagnostics Revenue Market Share by Application (2020-2025)
Figure 45. Middle East and Africa Influenza Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Middle East and Africa Influenza Diagnostics Revenue Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Influenza Diagnostics Revenue Market Share by Type (2020-2025)
Figure 48. Middle East and Africa Influenza Diagnostics Revenue Market Share by Application (2020-2025)
Figure 49. Influenza Diagnostics Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Influenza Diagnostics Raw Materials by Region in 2024
Figure 51. Influenza Diagnostics Distribution Channels
Figure 52. Global Influenza Diagnostics Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 53. Global Influenza Diagnostics Percentage 2020-2031: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Table 1. Global Influenza Diagnostics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Influenza Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Influenza Diagnostics Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Influenza Diagnostics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Influenza Diagnostics Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Influenza Diagnostics Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Influenza Diagnostics Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Influenza Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 11. Influenza Diagnostics Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Influenza Diagnostics Players by Revenue (US$ Million) in 2024
Table 13. Global Influenza Diagnostics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Influenza Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2024)
Table 15. Global Influenza Diagnostics Companies Headquarters
Table 16. Date of International Companies Enter into Influenza Diagnostics Market
Table 17. Global Influenza Diagnostics Companies Product & Service
Table 18. Global Influenza Diagnostics Mergers & Acquisitions, Expansion Plans
Table 19. BD Corporation Information
Table 20. BD Description and Business Overview
Table 21. BD Influenza Diagnostics Product
Table 22. BD Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. BD Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 24. BD Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 25. BD Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 26. BD Recent Developments
Table 27. Abbott (Include Alere) Corporation Information
Table 28. Abbott (Include Alere) Description and Business Overview
Table 29. Abbott (Include Alere) Influenza Diagnostics Product
Table 30. Abbott (Include Alere) Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Abbott (Include Alere) Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 32. Abbott (Include Alere) Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 33. Abbott (Include Alere) Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 34. Abbott (Include Alere) Recent Developments
Table 35. Roche Corporation Information
Table 36. Roche Description and Business Overview
Table 37. Roche Influenza Diagnostics Product
Table 38. Roche Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Roche Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 40. Roche Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 41. Roche Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 42. Roche Recent Developments
Table 43. SIEMENS Corporation Information
Table 44. SIEMENS Description and Business Overview
Table 45. SIEMENS Influenza Diagnostics Product
Table 46. SIEMENS Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. SIEMENS Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 48. SIEMENS Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 49. SIEMENS Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 50. SIEMENS Recent Developments
Table 51. Analytik Jena Corporation Information
Table 52. Analytik Jena Description and Business Overview
Table 53. Analytik Jena Influenza Diagnostics Product
Table 54. Analytik Jena Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Analytik Jena Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 56. Analytik Jena Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 57. Analytik Jena Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 58. Analytik Jena Recent Developments
Table 59. Quidel Corporation Information
Table 60. Quidel Description and Business Overview
Table 61. Quidel Influenza Diagnostics Product
Table 62. Quidel Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Quidel Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 64. Quidel Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 65. Quidel Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 66. Quidel Recent Developments
Table 67. Thermo Fisher Corporation Information
Table 68. Thermo Fisher Description and Business Overview
Table 69. Thermo Fisher Influenza Diagnostics Product
Table 70. Thermo Fisher Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 72. Thermo Fisher Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 73. Thermo Fisher Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 74. Thermo Fisher Recent Developments
Table 75. Meridian Bioscience Corporation Information
Table 76. Meridian Bioscience Description and Business Overview
Table 77. Meridian Bioscience Influenza Diagnostics Product
Table 78. Meridian Bioscience Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Meridian Bioscience Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 80. Meridian Bioscience Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 81. Meridian Bioscience Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 82. Meridian Bioscience Recent Developments
Table 83. BioMerieux Corporation Information
Table 84. BioMerieux Description and Business Overview
Table 85. BioMerieux Influenza Diagnostics Product
Table 86. BioMerieux Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. BioMerieux Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 88. BioMerieux Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 89. BioMerieux Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 90. BioMerieux Recent Developments
Table 91. Sekisui Diagnostics Corporation Information
Table 92. Sekisui Diagnostics Description and Business Overview
Table 93. Sekisui Diagnostics Influenza Diagnostics Product
Table 94. Sekisui Diagnostics Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Sekisui Diagnostics Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 96. Sekisui Diagnostics Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 97. Sekisui Diagnostics Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 98. Sekisui Diagnostics Recent Developments
Table 99. Response Biomedical Corporation Information
Table 100. Response Biomedical Description and Business Overview
Table 101. Response Biomedical Influenza Diagnostics Product
Table 102. Response Biomedical Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Response Biomedical Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 104. Response Biomedical Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 105. Response Biomedical Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 106. Response Biomedical Recent Developments
Table 107. SA Scientific Corporation Information
Table 108. SA Scientific Description and Business Overview
Table 109. SA Scientific Influenza Diagnostics Product
Table 110. SA Scientific Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. SA Scientific Revenue Proportion of Influenza Diagnostics by Product in 2024
Table 112. SA Scientific Revenue Proportion of Influenza Diagnostics by Application in 2024
Table 113. SA Scientific Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024
Table 114. SA Scientific Recent Developments
Table 115. North America Influenza Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 116. North America Influenza Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 117. North America Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 118. North America Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 119. Asia-Pacific Influenza Diagnostics Revenue by Region (2020-2025) & (US$ Million)
Table 120. Asia-Pacific Influenza Diagnostics Revenue by Region (2026-2031) & (US$ Million)
Table 121. Asia-Pacific Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 122. Asia-Pacific Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 123. Europe Influenza Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 124. Europe Influenza Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 125. Europe Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 126. Europe Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 127. Latin America Influenza Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 128. Latin America Influenza Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 129. Latin America Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 130. Latin America Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 131. Middle East and Africa Influenza Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 132. Middle East and Africa Influenza Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 133. Middle East and Africa Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 134. Middle East and Africa Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 135. Influenza Diagnostics Key Raw Materials, Industry Status and Trend
Table 136. Influenza Diagnostics Key Raw Materials and Upstream Suppliers
Table 137. Influenza Diagnostics Clients Status and Trend
Table 138. Influenza Diagnostics Typical Clients
Table 139. Influenza Diagnostics Distributors
Table 140. Influenza Diagnostics Market Trends
Table 141. Influenza Diagnostics Market Drivers
Table 142. Influenza Diagnostics Market Challenges
Table 143. Influenza Diagnostics Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Diagnostics Product Picture
Figure 2. Global Influenza Diagnostics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Influenza Diagnostics Revenue Market Share by Type in 2024 & 2031
Figure 4. RIDT Product Picture
Figure 5. RT-PCR Product Picture
Figure 6. Cell Culture Product Picture
Figure 7. Others Product Picture
Figure 8. Global Influenza Diagnostics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Influenza Diagnostics Revenue Market Share by Application in 2024 & 2031
Figure 10. Hospitals
Figure 11. POCT
Figure 12. Others
Figure 13. Influenza Diagnostics Report Years Considered
Figure 14. Global Influenza Diagnostics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Influenza Diagnostics Market Size (2020-2031) & (US$ Million)
Figure 16. Global Influenza Diagnostics Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Influenza Diagnostics Revenue Market Share by Region (2020-2031)
Figure 18. Global Influenza Diagnostics Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Influenza Diagnostics Revenue Market Share Forecast by Application (2020-2031)
Figure 20. RIDT of Influenza Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 21. RT-PCR of Influenza Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 22. Cell Culture of Influenza Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 23. Others of Influenza Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 24. Influenza Diagnostics Revenue Share by Company (2024)
Figure 25. Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. RIDT Revenue Proportion by Company in 2024
Figure 27. RT-PCR Revenue Proportion by Company in 2024
Figure 28. Cell Culture Revenue Proportion by Company in 2024
Figure 29. Others Revenue Proportion by Company in 2024
Figure 30. North America Influenza Diagnostics Revenue 2020-2031 (US$ Million)
Figure 31. North America Influenza Diagnostics Revenue Market Share by Type (2020-2025)
Figure 32. North America Influenza Diagnostics Revenue Market Share by Application (2020-2025)
Figure 33. Asia-Pacific Influenza Diagnostics Revenue 2020-2031 (US$ Million)
Figure 34. Asia-Pacific Influenza Diagnostics Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Influenza Diagnostics Revenue Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Influenza Diagnostics Revenue Market Share by Application (2020-2025)
Figure 37. Europe Influenza Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Influenza Diagnostics Revenue Market Share by Country (2020-2031)
Figure 39. Europe Influenza Diagnostics Revenue Market Share by Type (2020-2025)
Figure 40. Europe Influenza Diagnostics Revenue Market Share by Application (2020-2025)
Figure 41. Latin America Influenza Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Influenza Diagnostics Revenue Market Share by Country (2020-2031)
Figure 43. Latin America Influenza Diagnostics Revenue Market Share by Type (2020-2025)
Figure 44. Latin America Influenza Diagnostics Revenue Market Share by Application (2020-2025)
Figure 45. Middle East and Africa Influenza Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Middle East and Africa Influenza Diagnostics Revenue Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Influenza Diagnostics Revenue Market Share by Type (2020-2025)
Figure 48. Middle East and Africa Influenza Diagnostics Revenue Market Share by Application (2020-2025)
Figure 49. Influenza Diagnostics Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Influenza Diagnostics Raw Materials by Region in 2024
Figure 51. Influenza Diagnostics Distribution Channels
Figure 52. Global Influenza Diagnostics Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 53. Global Influenza Diagnostics Percentage 2020-2031: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232